BioMarin Pharmaceuticals
BMRN
BMRN
321 hedge funds and large institutions have $8.94B invested in BioMarin Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 128 increasing their positions, 103 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more funds holding
Funds holding: 313 → 321 (+8)
14% less capital invested
Capital invested by funds: $10.4B → $8.94B (-$1.45B)
Holders
321
Holding in Top 10
11
Calls
$140M
Puts
$100M
Top Buyers
1 | +$136M | |
2 | +$119M | |
3 | +$84.4M | |
4 |
Norges Bank
Oslo,
Norway
|
+$69.5M |
5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$36.7M |
Top Sellers
1 | -$278M | |
2 | -$182M | |
3 | -$166M | |
4 |
Capital World Investors
Los Angeles,
California
|
-$76.4M |
5 |
HCM
Holland Capital Management
Chicago,
Illinois
|
-$54.8M |